Data / Form D filings / Alpenglow Biosciences, Inc.
Alpenglow Biosciences, Inc.: Form D filings
Alpenglow Biosciences, Inc., a health care company in Seattle, WA, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on December 31, 2025, reports $3 million sold of a $3 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2121 N 35TH STREET, SUITE 100, Seattle, WA, 98103
- Phone
- (206) 659-7920
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1763787
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Amendment | $3,000,000 | $3,000,000 | 14 | Mar 7, 2024 | sec.gov | |
| Mar 25, 2024 | New notice | $4,850,000 | $1,800,000 | $3,050,000 | 4 | Mar 7, 2024 | sec.gov |
| Jun 22, 2021 | New notice | $4,782,784 | $4,582,788 | $199,996 | 11 | Jun 9, 2021 | sec.gov |
| Sep 10, 2019 | New notice | $750,000 | $300,000 | $450,000 | 2 | Sep 3, 2019 | sec.gov |
| Jan 7, 2019 | New notice | $350,000 | $100,000 | $250,000 | 2 | Dec 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniella T.C. Kranjac | Director | |
| Jonathan T.C. Liu | Director | |
| Nicholas P. Reder | Executive Officer, Director | |
| Michael T.C. Dutton | Executive Officer |
Other health care companies in Washington that filed recently
- Seattle Neurosound Solutions, Inc. $100,000 · Sep 22, 2026
- DexCare, Inc. $12.9 million · Sep 14, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in Washington · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Alpenglow Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.